Blogs

Filter search results

Filter

Showing 1 - 10 of 109 results

Profitable growth
Company
Gist Weekly: December 20, 2024

Congress scrambles for a new funding deal, a report details the financial impacts of a mandatory bundled payment model, and a woman receives a genetically modified pig kidney transplant. read more

Profitable growth
The Key Strategic Decisions Health Systems Faced in 2024…And What’s in Store for 2025

It has been an incredibly busy and exciting year for our Strategy & Business Transformation practice at Kaufman Hall. In 2024, we observed hospitals and health systems take steps to reinvigorate thei... read more

Profitable growth
Pharmacy
Company
Gist Weekly: December 13, 2024

Congress negotiates its year-end healthcare package, Dreamers lose access to ACA exchanges, and Elevance reverses its controversial anesthesia policy. read more

Profitable growth
Quality & clinical operations
Payers in 2025: A Case for Optimism, Agency, and Innovation Velocity

The future will favor payers that adapt to changing market circumstances with agency and velocity. Payers will need to make tough choices. read more

Financial sustainability
Company
Profitable growth
Be prepared. Be very prepared.

With extension of the 2017 tax cuts identified as a key priority for the incoming Trump administration, offsetting expense actions will be needed to avoid increasing the federal deficit. Hospital lea... read more

Profitable growth
Pharmacy
Company
Gist Weekly: December 6, 2024

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures. read more

Financial sustainability
Profitable growth
Will the Hospital Industry Finally Land Its First “Triple A”?

A growth strategy focused on access, accretive opportunities, and ambulatory represents a new “Triple A” for hospitals and health systems. read more

Profitable growth
Pharmacy
Quality & clinical operations
Gist Weekly: November 22, 2024

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again. read more

Company
Profitable growth
The Misadventures of Primary Care

Recent efforts to contemporize primary care have proven that the best intentions, the smartest ideas, and a lot of money are no guarantee of commercial success. Corporate America has found primary ca... read more

Pharmacy
Profitable growth
Gist Weekly: November 15, 2024

DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program. read more